Potential therapeutic benefit of spinal cord stimulation in restless legs syndrome: scoping review and mechanistic considerations

Pain Med. 2023 Oct 13;24(Supplement_2):S18-S23. doi: 10.1093/pm/pnad089.

Abstract

Background: Restless legs syndrome (RLS) is a prevalent sensorimotor disorder that can dramatically impair sleep quality, daytime function, and quality of life. Although many patients benefit from standard pharmacological therapy, some patients suffer from insufficient treatment response or medication intolerance. Novel treatment approaches are therefore necessary.

Objective: Given the overlap between RLS and pain syndromes in both pathophysiological mechanisms and certain treatment options, we aimed to perform a scoping review of the available evidence on spinal cord stimulation (SCS) for RLS and discuss potential mechanistic implications.

Methods: We identified a total of 16 cases of patients with RLS who underwent SCS, all from case reports or case series.

Discussion: The published evidence is insufficient to assess SCS efficacy in patients with RLS, but SCS remains a promising investigational therapy in RLS on the basis of its potential mitigatory effects in the central hyperexcitability of the sensorimotor cortex through neuromodulation of spinal, subcortical, and cortical areas. A call for further research in this field is presented, with suggestions for future directions and trial designs.

Keywords: RLS; neuromodulation; neurostimulation; spinal cord stimulator.

Publication types

  • Review

MeSH terms

  • Humans
  • Quality of Life
  • Restless Legs Syndrome* / drug therapy
  • Restless Legs Syndrome* / etiology
  • Spinal Cord Stimulation*